Sign In
Buy MDWD
$13.73
-0.0300 (-0.218%)
At Close: Jun 03, 2026
MediWound Continues Global Expansion with Distribution Agreement for NexoBrid in United Arab Emirates with Ghassan Aboud Group
04:15pm, Monday, 14'th Dec 2020
YAVNE, Israel, Dec. 14, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wou
MediWound Ltd. (MDWD) CEO Sharon Malka on Q3 2020 Results - Earnings Call Transcript
03:31pm, Tuesday, 10'th Nov 2020
MediWound Ltd. (MDWD) CEO Sharon Malka on Q3 2020 Results - Earnings Call Transcript
MediWound: Q3 Earnings Insights
07:33am, Tuesday, 10'th Nov 2020
Shares of MediWound (NASDAQ:MDWD) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share rose 36.36% over the past year to ($0.07), which beat the estimate of
MediWound Reports Third Quarter 2020 Financial Results
07:00am, Tuesday, 10'th Nov 2020
Total Third Quarter R evenues of $6.6 Million Increased 29 % Y ear-over- Y ear
MediWound to Report Third Quarter 2020 Financial Results and Host a Conference Call and Webcast on November 10, 2020
04:01pm, Monday, 02'nd Nov 2020
YAVNE, Israel, Nov. 02, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wou
MediWound Completes Enrollment Stage of its NexoBrid Phase 3 Pediatric Study
07:00am, Wednesday, 28'th Oct 2020
Top-line Data is Expected in the Second Half of 2021 Top-line Data is Expected in the Second Half of 2021
MediWound: An Underfollowed Opportunity At A Discount
12:16pm, Tuesday, 08'th Sep 2020
MediWound has popped up on my scanner multiple times over the past few years but the conditions never lined up for me to establish a position.
MediWound (MDWD) Reports Q2 Loss, Lags Revenue Estimates
04:35pm, Thursday, 06'th Aug 2020
MediWound (MDWD) delivered earnings and revenue surprises of 0.00% and -15.84%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
MediWound Reports Second Quarter 2020 Financial Results and Provides Corporate Update
11:00am, Thursday, 06'th Aug 2020
Submitted Biological License Application to the FDA for NexoBrid EscharEx U.S. Phase 2 Study Resumed Patient ScreeningYAVNE, Israel, Aug. 06, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD)
Should MediWound (NASDAQ:MDWD) Be Disappointed With Their 52% Profit?
06:53pm, Friday, 31'st Jul 2020
The simplest way to invest in stocks is to buy exchange traded funds. But if you pick the right individual stocks, you...
MediWound (MDWD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
04:33pm, Thursday, 30'th Jul 2020
MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MediWound to Report Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on August 6, 2020
12:00pm, Tuesday, 28'th Jul 2020
YAVNE, Israel, July 28, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wou
MediWound (MDWD) Jumps: Stock Rises 9.4%
12:54pm, Tuesday, 14'th Jul 2020
MediWound (MDWD) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet medical needs in severe burn and wound management, today announced it has submitted a
Zacks.com featured highlights include: MediWound, Issuer Direct, BWX Technologies and Teekay Tankers
02:29pm, Wednesday, 27'th May 2020
Zacks.com featured highlights include: MediWound, Issuer Direct, BWX Technologies and Teekay Tankers
